Want to track DHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days
Summary
DHR trading today higher at $207.54, an increase of 0.88% from yesterday's close, completing a monthly increase of 6.25% or $12.21. Over the past 12 months, DHR stock lost -10.1%.
DHR pays dividends to its shareholders, with the most recent payment made on Jul 25, 2025. The next estimated payment will be in In 2 months on Oct 25, 2025 for a total of $0.32.
The last earnings report, released on Jul 22, 2025, exceeded the consensus estimates by 0.16%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports. The next scheduled earnings report is due on Oct 20, 2025.
Danaher Corporation has completed 7 stock splits, with the recent split occurring on Oct 02, 2023.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).
DHR Chart
CVS or DHR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Zacks | 1 day ago
International Markets and Danaher (DHR): A Deep Dive for Investors
Explore how Danaher's (DHR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Zacks | 2 weeks ago
Investors decided the good outweighs the bad with Danaher, says Jim Cramer
'Mad Money' host Jim Cramer talks how to play Danaher after earnings.
Youtube | 2 weeks ago
Danaher Corporation Dividends
 DHR In 1 month Estimated | Quarterly | $0.32 Per Share |
| DHR 1 month ago Paid | Quarterly | $0.32 Per Share |
| DHR 4 months ago Paid | Quarterly | $0.32 Per Share |
| DHR 7 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 10 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 28 Jun 2024 Paid | Quarterly | $0.27 Per Share |
Danaher Corporation Earnings
| 28 Oct 2025 (In 2 months) Date | | 1.73 Cons. EPS | - EPS |
| 21 Oct 2025 (In 2 months) Date | | 1.73 Cons. EPS | - EPS |
| 20 Oct 2025 (In 2 months) Date | | 1.8 Cons. EPS | - EPS |
| 22 Jul 2025 Date | | 1.64 Cons. EPS | 1.8 EPS |
| 21 Jul 2025 Date | | - Cons. EPS | - EPS |
| DHR In 1 month Estimated | Quarterly | $0.32 Per Share |
| DHR 1 month ago Paid | Quarterly | $0.32 Per Share |
| DHR 4 months ago Paid | Quarterly | $0.32 Per Share |
| DHR 7 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 10 months ago Paid | Quarterly | $0.27 Per Share |
| DHR 28 Jun 2024 Paid | Quarterly | $0.27 Per Share |
| 28 Oct 2025 (In 2 months) Date | | 1.73 Cons. EPS | - EPS |
| 21 Oct 2025 (In 2 months) Date | | 1.73 Cons. EPS | - EPS |
| 20 Oct 2025 (In 2 months) Date | | 1.8 Cons. EPS | - EPS |
| 22 Jul 2025 Date | | 1.64 Cons. EPS | 1.8 EPS |
| 21 Jul 2025 Date | | - Cons. EPS | - EPS |
Danaher Corporation (DHR) FAQ
What is the stock price today?
The current price is $207.54.
On which exchange is it traded?
Danaher Corporation is listed on NYSE.
What is its stock symbol?
The ticker symbol is DHR.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.08%.
What is its market cap?
As of today, the market cap is 139.75B.
What is the earnings per share?
The EPS is 1.8.
When is the next earnings date?
The next earnings report will release on Oct 20, 2025.
Has Danaher Corporation ever had a stock split?
Danaher Corporation had 7 splits and the recent split was on Oct 02, 2023.
Danaher Corporation Profile
| Medical - Diagnostics & Research Industry | Healthcare Sector | Rainer M. Blair CEO | NYSE Exchange | 235851102 Cusip |
| US Country | 61,000 Employees | 28 Mar 2025 Last Dividend | 2 Oct 2023 Last Split | 5 Jan 1979 IPO Date |
Overview
Danaher Corporation is a global powerhouse in the design, manufacturing, and marketing of a vast array of professional, medical, industrial, and commercial products and services. With its inception in 1969 and a significant rebranding in 1984, where it transitioned from Diversified Mortgage Investors, Inc. to Danaher Corporation, the company has established a formidable presence in various sectors. Headquartered in Washington, D.C., Danaher stands out through its commitment to innovation, excellence, and enhancing the quality of life worldwide.
Products and Services
- Biotechnology: Danaher's biotechnology segment is a provider of bioprocess technologies, consumables, and services enhancing the development and manufacture of therapeutics. This includes cell line and cell culture media development, chromatography resins, filtration technologies, aseptic fill-finish solutions, single-use hardware, and comprehensive services aimed at setting up full manufacturing suites.
- Life Sciences: This segment delivers a wide range of products including mass spectrometers, flow cytometry, genomics solutions, lab automation instruments, centrifugation, liquid handling automation instruments, antibodies and reagents, particle counting and characterization tools, microscopes, and protein consumables. Among the notable brands under the Life Sciences segment are ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX, each providing specialized products for genomic medicines and industrial filtration.
- Diagnostics: Danaher’s diagnostics sector offers a comprehensive range of chemistry, immunoassay, microbiology, automation systems, molecular diagnostics, acute care, and pathology diagnostics products. Aimed at hospitals, physicians' offices, reference laboratories, and other critical care settings, this segment ensures the delivery of clinical instruments, reagents, consumables, software, and dedicated services to support critical diagnostics.
Contact Information
Address: 2200 Pennsylvania Avenue, NW
Phone: 202 828 0850
Website: https://www.danaher.com
2025 © Marketlog. All Rights Reserved.
